Linaclotide
Gastrointestinal & peptide biology
A guanylate cyclase C agonist with a defined GC-C/cGMP mechanism and randomised trial evidence in specified constipation related disorders; authorised uses depend on the finished product, population and jurisdiction.
An authorisation applies to at least one defined finished product in a stated jurisdiction; it does not apply automatically to this catalogue material.
What is Linaclotide?
Linaclotide is a synthetic peptide agonist of guanylate cyclase C used in gastrointestinal research, notably in models of IBS C and chronic constipation; the catalogue entry denotes the research grade peptide compound.
Which research context has Linaclotide been associated with?
Linaclotide is associated with gastrointestinal pharmacology research as a guanylate cyclase C agonist that increases epithelial cGMP signalling. Randomised trials of defined finished products reported improved bowel and abdominal symptom outcomes versus placebo in specified constipation related disorders. Authorisation, formulation, age limits and indications depend on the product and jurisdiction; this catalogue listing does not itself establish a clinically equivalent or authorised product.
What documentation is available for Linaclotide?
Linaclotide: Batch documents are not yet linked on this site. For this synthetic guanylate cyclase C agonist peptide the checklist comprises batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity specification; peptide content, counterion and residual solvent/water details; and potency/assay documentation. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Linaclotide?
Linaclotide: Storage depends on the documented supplied presentation; for this synthetic guanylate cyclase C agonist peptide confirm dry/lyophilised versus solution form, counterion and concentration, solvent or buffer selection, pH sensitivity, container closure compatibility and assessment of cysteine/disulfide or conformational integrity affecting stability. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.